In the Press

Read the latest press releases for ColoTect & keep up to date nationally and internationally

Discover the lasted Cancer Preventative technologies

AT HOME LAB TEST FOR EARLY CANCER DETECTION ,DELIVERED ON DEMAND

Image Gallery

There may be no better way to communicate what we do than through images. As you browse our site, take a few moments to let your eyes linger here, and see if you can get a feel for our signature touch.

BGI COLOTECT 3.0 demonstrates higher colorectal cancer detection sensitivity than FIT

SAN FRANCISCO, Feb. 7, 2023 /PRNewswire/ -- COLOTECT 3.0, a multi-target fecal DNA test outperforms fecal immunochemical tests (FIT) in terms of detection of colorectal cancer and advanced precancerous lesions.

BGI Genomics, a global life sciences company providing integrated solutions of precision medicine, presented case-control study data on its COLOTECT 3.0 non-invasive colorectal cancer screening test at the 2023 ASCO Gastrointestinal Cancers Symposium (ASCO GI 2023) and announced plans for further global clinical studies.

In the Press

Discover the lasted Cancer Preventative technologies

AT HOME LAB TEST FOR EARLY CANCER DETECTION ,DELIVERED ON DEMAND

Image Gallery

Contact Us

Payment Methods Accepted

Address

Operation Hours

Contact